Research Article

Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience

Table 5

Kaplan-Meier survival estimates for entire cohort.

Recurrence-free survivalAdvanced recurrence-free survivalOverall survival

Median time to IQR in months23 (5.9–66.2)66 (7.2–not reached)79 (20.6–not reached)
2-year (95% CI)37% (18.6–56.4%)58% (37.4–74.3%)71% (48.2–85.5%)
5-year (95% CI)28% (9.7–50.1%)51% (28.6–69.5%)63% (37.6–80.9%)

IQR: interquartile range; CI: confidence interval.